Neurogenesis Inc
Neurogenesis, Inc. manufactures and sells nutritional supplements primarily in the United States. The company offers NeuBecalm'd, a nutritional supplement to reduce the effects of acute and chronic stress factors; NeuBecalm'd Chewables that reduces the effects of stress and enhance focus; and NeuRecover, a nutritional support for the natural replenishment of neurotransmitters depleted by the long… Read more
Market Cap & Net Worth: Neurogenesis Inc (NEUN)
Neurogenesis Inc (PINK:NEUN) has a market capitalization of $8.23K ($8.23K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #51449 globally and #16116 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Neurogenesis Inc's stock price $0.00 by its total outstanding shares 82262096 (82.26 Million).
Neurogenesis Inc Market Cap History: 2015 to 2025
Neurogenesis Inc's market capitalization history from 2015 to 2025. Data shows change from $205.66K to $8.23K (-31.34% CAGR).
Neurogenesis Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Neurogenesis Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of NEUN by Market Capitalization
Companies near Neurogenesis Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Neurogenesis Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Neurogenesis Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Neurogenesis Inc's market cap moved from $205.66K to $ 8.23K, with a yearly change of -31.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $8.23K | 0.00% |
| 2024 | $8.23K | 0.00% |
| 2023 | $8.23K | -98.67% |
| 2022 | $616.97K | 0.00% |
| 2021 | $616.97K | +127.27% |
| 2020 | $271.46K | -61.63% |
| 2019 | $707.45K | +75.51% |
| 2018 | $403.08K | +122.73% |
| 2017 | $180.98K | -15.38% |
| 2016 | $213.88K | +4.00% |
| 2015 | $205.66K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Neurogenesis Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.23K USD |
| MoneyControl | $8.23K USD |
| MarketWatch | $8.23K USD |
| marketcap.company | $8.23K USD |
| Reuters | $8.23K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.